New HampshireHB17722025-2026 Regular SessionHouseWALLET

(Second New Title) relative to prescribing ibogaine for investigational use only and adopting the physician associate licensure compact.

Sponsored By: Michael I Moffett (Republican)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

5 provisions identified: 2 benefits, 1 costs, 2 mixed.

Patients gain research-only access to ibogaine

Licensed physicians and other qualified licensed practitioners can give ibogaine only through FDA-approved research protocols. Federal law and the study protocol must allow the use. This does not allow general ibogaine treatment outside approved research. The law takes effect 60 days after passage.

Physician associates gain an interstate practice pathway

New Hampshire joins a compact allowing eligible physician associates to practice across participating states without separate state licenses. The compact commission starts operating once seven states join. Applicants need a qualifying unrestricted license, approved education, current national certification, and required background checks. Disqualifying convictions, license actions, or pending actions can block access; applicants must also meet the destination state's legal-knowledge requirements. Certain past restrictions trigger a two-year wait after removal; restrictions on a qualifying license deactivate interstate privileges during the restriction and for two years afterward. Associates must follow the patient's state's practice and controlled-medicine rules, report address changes, and accept legal notices at their primary address. New Hampshire must handle licensing, complaints, background checks, and required reporting; privileges generally last until the qualifying license expires or is revoked.

Interstate practice can bring new provider fees

Participating states can charge physician associates for interstate practice privileges, but the law sets no required state fee or amount. The commission can also charge licensees privilege fees and participating states annual assessments. Its rules set the amounts, and its finances require adequate funding and audited records. The fiscal note estimates $10,000 in one-time New Hampshire software costs and a potential $93,000 annual loss in license revenue. These are estimates, not appropriations; the law sets no direct patient charge or consumer tax change.

Interstate licensing rules gain force and safeguards

A commission with one delegate per participating state makes binding rules without each state's usual rulemaking process. Courts can invalidate rules exceeding its authority or conflicting with state laws on physician associates' allowed medical services. A majority of participating-state legislatures can reject a rule within four years after adoption. States must enforce the compact and share licensing, discipline, and significant investigation data through a secure system with disclosure limits. States retain authority over their own licenses; other participating states can limit local privileges, but cannot punish conduct lawful in the licensing state.

State exits affect physician associates' practice rights

After other compliance efforts fail, a majority of state delegates can remove a state that has not fixed compact violations. The state still owes assessments and other obligations incurred through termination. Existing practice privileges generally continue for 180 days after termination. Associates can retain privileges beyond that period by holding or obtaining a qualifying license in another participating state before the deadline. A state can also withdraw by repealing its compact law; withdrawal takes effect after 180 days, with temporary protections for existing privileges.

Sponsors & Cosponsors

Sponsor

  • Michael I Moffett

    Republican • House

Cosponsors

  • Howard Pearl

    r • Senate

  • Jess Edwards

    Republican • House

  • Keith Michael Ammon

    Republican • House

  • Lily M Foss

    Democratic • House

  • Lisa M Freeman

    Affiliation unavailable

  • Terry W Roy

    Republican • House

  • Tim McGough

    Republican • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Signed by Governor Ayotte 07/15/2026; Chapter 333; eff. 09/13/2026

    7/20/2026House
  2. Enrolled Adopted, VV, (In recess 06/04/2026); SJ 15

    7/6/2026Senate
  3. Enrolled (in recess of) 06/04/2026 HJ 15 P. 56

    7/6/2026House
  4. Enrolled Bill Amendment # 2026-2184e: AA VV (in recess of) 06/04/2026 HJ 15 P. 53

    6/23/2026House
  5. Enrolled Bill Amendment # 2026-2184e Adopted, VV, (In recess of 06/04/2026); SJ 14

    6/23/2026Senate
  6. Conference Committee Report 2026-2090c: Adopted, VV 06/04/2026 HJ 15 P. 13

    6/4/2026House
  7. Conference Committee Report # 2026-2090c, Adopted, VV; 06/04/2026; SJ 14

    5/29/2026Senate
  8. Conference Committee Report Filed, # 2026-2090c; 06/04/2026

    5/28/2026Senate
  9. Conference Committee Meeting: 05/27/2026 01:45 pm GP 231

    5/27/2026House
  10. President Appoints: Senators Rochefort, Pearl, Prentiss; (In Recess 05/14/2026); SJ 13

    5/20/2026Senate
  11. Sen. Rochefort Accedes to House Request for Committee of Conference, MA, VV; (In recess 05/14/2026); SJ 13

    5/20/2026Senate
  12. Speaker Appoints: Reps. W. MacDonald, Drew, Markell, Milz 05/14/2026 HJ 13 P. 152

    5/20/2026House
  13. House Non-Concurs with Senate Amendment 2026-1916s and 2026-1623s and Requests CofC (Rep. W. MacDonald): MA VV 05/14/2026 HJ 13 P. 152

    5/20/2026House
  14. Ought to Pass with Amendments #2026-1623s and #2026-1916s, MA, VV; OT3rdg; 05/14/2026; SJ 12

    5/14/2026Senate
  15. Sen. Rochefort Floor Amendment # 2026-1916s, AA, VV; 05/14/2026; SJ 12

    5/14/2026Senate
  16. Committee Amendment # 2026-1623s, AA, VV; 05/14/2026; SJ 12

    5/14/2026Senate
  17. Committee Report: Ought to Pass with Amendment # 2026-1623s, 05/14/2026, Vote 4-0; SC 18

    5/7/2026Senate
  18. Special Order to 05/14/2026, Without Objection, MA; 05/07/2026 SJ 11

    5/7/2026Senate
  19. Committee Report: Ought to Pass with Amendment # 2026-1623s, 05/07/2026, Vote 4-0; SC 17

    4/22/2026Senate
  20. Hearing: 03/25/2026, Room 100, SH, 10:00 am; SC 12

    3/24/2026Senate
  21. Introduced 03/12/2026 and Referred to Health and Human Services; SJ 7

    3/17/2026Senate
  22. Amendment # 2026-0365h: AA VV 03/11/2026 HJ 7 P. 206

    3/11/2026House
  23. Ought to Pass with Amendment 2026-0365h: MA DV 176-156 03/11/2026 HJ 7 P. 207

    3/11/2026House
  24. Minority Committee Report: Refer for Interim Study

    3/4/2026House
  25. Majority Committee Report: Ought to Pass with Amendment # 2026-0365h 03/04/2026 (Vote 10-8; RC) HC 10 P. 53

    3/4/2026House

Bill Text

  • As Amended

    6/23/2026

  • Enrolled

    6/23/2026

  • Introduced

    12/17/2025

  • CHAPTERED FINAL VERSION

  • Version adopted by both bodies

Related Bills

Back to State Legislation